Boston Scientific | BSX

Stock Price
77.16
Daily Change
1.02 1.34%
Monthly
6.07%
Yearly
51.08%
Q2 Forecast
75.07
Peers Price Chg Day Year Date
Abbott 107.58 3.48 3.34% 6.75% Jun/07
AtriCure 22.42 -0.16 -0.71% -53.16% Jun/07
Avanos Medical 19.76 -0.40 -1.98% -22.69% Jun/07
Baxter International 33.15 -0.12 -0.36% -19.82% Jun/07
Becton, Dickinson and Co. 240.64 0.59 0.25% -3.55% Jun/07
Boston Scientific 77.16 1.02 1.34% 51.08% Jun/07
CONMED 76.41 -0.52 -0.68% -41.97% Jun/07
Cooper Companies 94.38 -0.79 -0.83% 7.93% Jun/07
Danaher 263.09 -4.83 -1.80% 11.76% Jun/07
Dexcom 115.83 0.56 0.49% -4.38% Jun/07
Edwards Lifesciences 88.16 0.49 0.55% 5.00% Jun/07
Globus Medical 65.12 -1.06 -1.60% 16.47% Jun/07
Hologic 74.51 -0.18 -0.24% -4.69% Jun/07
Integra LifeSciences 30.80 -0.31 -1.00% -24.79% Jun/07
Illumina 113.69 -1.02 -0.89% -43.92% Jun/07
Intuitive Surgical 417.61 -0.36 -0.09% 34.36% Jun/07
J&J 147.06 0.69 0.47% -8.24% Jun/07
Masimo 125.46 0.66 0.53% -20.29% Jun/07
Medtronic 84.07 1.67 2.03% 1.17% Jun/07
Merit Medical Systems 82.38 -1.18 -1.41% -2.23% Jun/07
Insulet 191.27 -0.72 -0.37% -32.01% Jun/07
Stryker 349.33 0.41 0.12% 26.22% Jun/07
Teleflex 212.32 -3.97 -1.84% -11.00% Jun/07
Tandem Diabetes Care 48.85 -0.72 -1.45% 102.03% Jun/07
Zimmer Biomet Holdings 113.11 -0.19 -0.17% -16.39% Jun/07

Indexes Price Day Year Date
US500 5347 -5.97 -0.11% 24.52% Jun/07

Boston Scientific traded at $77.16 this Friday June 7th, increasing $1.02 or 1.34 percent since the previous trading session. Looking back, over the last four weeks, Boston Scientific gained 6.07 percent. Over the last 12 months, its price rose by 51.08 percent. Looking ahead, we forecast Boston Scientific to be priced at 75.07 by the end of this quarter and at 73.70 in one year, according to Trading Economics global macro models projections and analysts expectations.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.